These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prostatic enzymes and abnormal bleeding. SCOTT EV Trans Southeast Sect Am Urol Assoc; 1955; (19th Meeting):50-5; discussion, 56-7. PubMed ID: 13274457 [No Abstract] [Full Text] [Related]
3. Fibrinolysis in patients with metastatic carcinoma of the prostate gland. DOLAZ EJ; DOLEHIDE RA; FRIEDMAN IA Ill Med J; 1955 Mar; 107(3):142-4. PubMed ID: 14353517 [No Abstract] [Full Text] [Related]
4. [Studies on fibrinolysis in hemorrhagic diathesis]. WALTHER G Arztl Forsch; 1958 Mar; 12(3):I/157-60. PubMed ID: 13533073 [No Abstract] [Full Text] [Related]
5. FIBRINOLYTIC ACTIVITY IN HUMAN BLOOD ASSAYED IN A PEPTONE-LIKE SYSTEM. BRAKMAN P; ASTRUP T Sangre (Barc); 1964; 61():46-50. PubMed ID: 14214884 [No Abstract] [Full Text] [Related]
6. Quantitative measurements of a fibrinolysin inhibitor in the plasma of various species. GUEST MM; DALY BM Fed Proc; 1947; 6(1 Pt 2):118. PubMed ID: 20244169 [No Abstract] [Full Text] [Related]
7. [Complex hemorrhagic diathesis with fibrinolysis in cancer of prostate]. CROIZAT P; REVOL L; FAVRE-GILLY J; THOUVEREZ JP Lyon Med; 1955 Apr; 87(17):397-403. PubMed ID: 14382726 [No Abstract] [Full Text] [Related]
8. [Hemorrhagic syndrome: the problem of fibrin]. DELAGE JM Laval Med; 1954 Nov; 19(9):1235-42. PubMed ID: 13234586 [No Abstract] [Full Text] [Related]
10. [2 cases of fibrinolysis in the course of protacaval anastomosis for cirrhosis revealed by detailed peroperative study of coagulation and treated with success by the pancreatic inhibitor CY-66]. GERMAIN A; AUVERT J; FAURE J; BLATRIX C; SAMAMA M Mem Acad Chir (Paris); 1961 Feb 1-8; 87():162-5. PubMed ID: 13704645 [No Abstract] [Full Text] [Related]
11. [Role of fibrin and fibrinolysis in the integrity of the vascular wall]. COPLEY AL Hemostase; 1963 Mar; 3():13-35. PubMed ID: 14022899 [No Abstract] [Full Text] [Related]
12. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. Ehrbar M; Metters A; Zammaretti P; Hubbell JA; Zisch AH J Control Release; 2005 Jan; 101(1-3):93-109. PubMed ID: 15588897 [TBL] [Abstract][Full Text] [Related]
13. Plasminogen assay by means of the lysis time method. Berg W; Korsan-Bengtsen K; Ygge J Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971 [TBL] [Abstract][Full Text] [Related]
14. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule. Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865 [TBL] [Abstract][Full Text] [Related]
15. [Analysis, by immuno-chemical methods, of the degradation by plasmin of human fibrinogen and fibrin, at different stages]. NUSSENZWEIG V; SELIGMANN M Nouv Rev Fr Hematol; 1960; 15():451-66. PubMed ID: 13729935 [No Abstract] [Full Text] [Related]